FIGURE 4.
Changes in the inflammatory markers in the Tocilizumab‐ and the standard‐of‐care‐treated groups during the first 14 days of the observation period
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.